Instrument Name Cloudmd Software & Services Inc (DOC-X) TSX Venture.
Similarly Is CloudMD undervalued? In other words, CloudMD stock is trading at a forward price-to-revenue ratio of 2.4. That makes it considerably undervalued. At $1.47 a share, CloudMD is relatively cheap for any investor looking to gain exposure on the tech side and healthcare side.
Is Doc stock a good buy? CloudMD(DOC-X) Rating
A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.
Additionally, Does CloudMD pay dividends?
CVE:DOC has not paid any dividends yet.
Is Doc A Good Investment?
Out of 7 analysts, 0 (0%) are recommending DOC as a Strong Buy, 0 (0%) are recommending DOC as a Buy, 7 (100%) are recommending DOC as a Hold, 0 (0%) are recommending DOC as a Sell, and 0 (0%) are recommending DOC as a Strong Sell. What is DOC’s earnings growth forecast for 2022-2024?
Is CloudMD on Nasdaq? CloudMD Software & Services Inc (DOCRF) Stock Price, Quote, News & History | Nasdaq.
